Absence of the lysophosphatidic acid receptor LPA1 results in abnormal bone development and decreased bone mass
Authors:
- Isabelle GenneroIGIsabelle Gennero
- Sara Laurencin-DalicieuxSLSara Laurencin-Dalicieux
- Fabienne Briand-MésangeFBFabienne Briand-Mésange
- Danielle LaurencinDLDanielle Laurencin
- Jackie RueJRJackie Rue
- Nicolas BetonNBNicolas Beton
- Nicole MaletNMNicole Malet
- Marianne MusMMMarianne Mus
- Akira TokumuraATAkira Tokumura
- Philippe BourinPBPhilippe Bourin
- Laurence VicoLVLaurence Vico
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Regulation of gene expression and subcellular protein distribution in MLO-Y4 osteocytic cells by lysophosphatidic acid: Relevance to dendrite outgrowthBone, 2011
- International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid Receptor NomenclaturePharmacological Reviews, 2010
- Genetics of OsteoporosisEndocrine Reviews, 2010
- Aiming drug discovery at lysophosphatidic acid targetsBritish Journal of Pharmacology, 2010
- Lysophosphatidic Acid Signals through Multiple Receptors in Osteoclasts to Elevate Cytosolic Calcium Concentration, Evoke Retraction, and Promote Cell SurvivalJournal of Biological Chemistry, 2010
- Lysophosphatidic acid (LPA) receptors: Signaling properties and disease relevanceProstaglandins & Other Lipid Mediators, 2010
- LPA Receptors: Subtypes and Biological ActionsAnnual Review of Pharmacology and Toxicology, 2010
- Lrp5 Controls Bone Formation by Inhibiting Serotonin Synthesis in the DuodenumCell, 2008
- P2X7 receptors on osteoblasts couple to production of lysophosphatidic acid: a signaling axis promoting osteogenesisJournal of Cell Biology, 2008
- Infrared imaging microscopy of bone: Illustrations from a mouse model of Fabry diseaseBiochimica et Biophysica Acta (BBA) - Biomembranes, 2006